TYROBP and neoplasm: The miR-183 targets low-density lipoprotein receptor-related protein in 3T3-L1 cells, promoting differentiation and adipogenesis by interfering with the Wnt/β catenin pathway (156) and tumor-derived TGF-β promotes miR-183 expression, silencing NK cells, through a mechanism mediated by DAP12 suppression.